MAAT INDEX

CLAIM #64774 · Varonis Systems (VRNS) · 2022Q3 earnings call · Oct 31, 2022 · due Dec 31, 2023

And that's why we're also giving our free cash flow expectation for 2023, which shows meaningful improvement compared to what we expect to finish in 2022.

Guy Melamed · CFO

CANNOT_DETERMINE
resolved by a revision, graded at the moved level · official band 5 percent
Committed
giving our free cash flow expectation for 2023, which shows meaningful improvement compared to what we expect to finish in 2022
Reported
Free cash flow of $40 million to $45 million, which includes $8 million to $10 million of headwinds related to the TCJA capitalization of R&D provision

How to check this claim

Look at: Free cash flow, fiscal year (as reported by Varonis)

It came true if: FY2023 free cash flow greater than FY2022 free cash flow

Where: Company press release / 10-K cash flow statement or shareholder letter reporting free cash flow

In context

Yaki mentioned. So all-in-all, that results in $7 million of savings you said. So what are these other initiatives outside of head count? And comparatively, how much contributions do you expect overall? And if you can talk about that and if the sales will be onetime or longer term? Just some color. Guy Melamed: We want to continue to balance the top line growth and cash flow improvements. And as you mentioned, you can see in our Q4 guidance that we managed to offset half of the revenue reduction with cost savings to protect profitability and cash flow. We went through our entire spend and try to see where we can cut and be more efficient. And at the end of the day, we're always looking at ways to be more efficient. And today's announcement is really about continuing to do the right thing. And that's why we're also giving our free cash flow expectation for 2023, which shows meaningful improvement compared to what we expect to finish in 2022. Operator: This concludes our question-and-answer session. I would like to turn the call back over to management for closing comments. Guy Melamed: Thanks for joining us today and thank you for your interest in Varonis. Operator: Thank you. This does conclude today's conference. You may disconnect your lines at this time, and thank you for your participation.

Verify independently

SEC filings for VRNS · Claim quote is verbatim from the 2022Q3 earnings call.